| Berea Walk-in Clinic | |
|
245 Prince Royal Dr Suite A Berea KY 40403-1471 | |
| (859) 582-7663 | |
| (859) 335-1560 |
| Full Name | Berea Walk-in Clinic |
|---|---|
| Speciality | Internal Medicine |
| Location | 245 Prince Royal Dr, Berea, Kentucky |
| Authorized Official Name and Position | Fadi Bacha (PRESIDENT/OWNER) |
| Authorized Official Contact | 8593129674 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Berea Walk-in Clinic 245 Prince Royal Dr Suite A Berea KY 40403-1471 Ph: (859) 582-7663 | Berea Walk-in Clinic 245 Prince Royal Dr Suite A Berea KY 40403-1471 Ph: (859) 582-7663 |
| NPI Number | 1437574613 |
|---|---|
| Provider Enumeration Date | 02/25/2014 |
| Last Update Date | 02/25/2014 |
| Medicare PECOS PAC ID | 6901039197 |
|---|---|
| Medicare Enrollment ID | O20140423001232 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437574613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 32006 (Kentucky) | Primary |
| 363A00000X | Physician Assistant | PA1103 (Kentucky) | Secondary |
| 363L00000X | Nurse Practitioner | 3008382 (Kentucky) | Secondary |
| Provider Name | Fadi Bacha |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639157456 PECOS PAC ID: 6305741067 Enrollment ID: I20031204001159 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
| Provider Name | Rezkalla A Butros |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1023037082 PECOS PAC ID: 1557268331 Enrollment ID: I20040513000932 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
| Provider Name | Nicola Jabbour |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1740485168 PECOS PAC ID: 1254456189 Enrollment ID: I20100916000142 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
| Provider Name | Elena Baker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598139842 PECOS PAC ID: 6305140492 Enrollment ID: I20160210001617 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
| Provider Name | Kristin Johnsen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245783554 PECOS PAC ID: 4284922659 Enrollment ID: I20161018001718 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
| Provider Name | Stephanie Warren |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073096616 PECOS PAC ID: 6406100601 Enrollment ID: I20181106002259 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
| Provider Name | Emily D Mcalister |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1427660893 PECOS PAC ID: 7416367180 Enrollment ID: I20201109001204 |
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
News Archive
Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.
With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.
Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.
iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.
Researchers from Vanderbilt University Medical Center (VUMC) are conducting a clinical trial to determine whether nasal saline irrigations can reduce viral shedding and symptoms in patients with COVID-19.
› Verified 7 days ago
White House Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 104 Legacy Dr, Berea, KY 40403 Phone: 859-986-2323 Fax: 859-986-7728 | |
Berea Hospitalists Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 305 Estill St, Berea, KY 40403 Phone: 859-986-3151 | |
Department Of Veterans Affairs Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 209 Pauline Dr, Berea, KY 40403 Phone: 859-233-4511 Fax: 859-986-1289 | |
Faith Dental Of Berea Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 206 Richmond Rd N, Berea, KY 40403 Phone: 859-986-8491 | |
Berea Health Ministry, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 305 Estill Street, Berea, KY 40403 Phone: 859-986-1274 Fax: 859-986-1279 | |
Dr. Gary E. King Optometrist Psc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 109 Boone St, Berea, KY 40403 Phone: 859-986-7027 Fax: 859-986-4749 |